maximum weight loss tirzepatide surmount trials For the first time, and semaglutide were put in the same trial. SURMOUNT-5. Phase 3b RCT. 751 adults with obesity, no diabetes. 72 weeks. Both drugs at tolerated dose. The Weight reduction over time in

Choosing the right syringe for microdosing Standard insulin syringes come in three sizes: 30-unit (0.3 mL), 50-unit (0.5 mL), and 100-unit (1.0 mL)

Metrics to track Beyond weight, track these metrics weekly or biweekly: Waist circumference at the navel, first thing in the morning Hip circumference at the widest point Energy level on a 1 to 10 scale Sleep quality on a 1 to 10 scale Appetite level on a 1 to 10 scale Side effects type and severity Exercise type and duration Request blood work from your provider at baseline, 12 weeks, and 24 weeks at minimum

www.accessdata.fda.gov/drugsatfda_docs/label/2018/206321s007lbl.pdf Wegovy US, Package Insert (Novo Nordisk, 2021)

In closing A short commentary today

The answer is not a straightforward yes or no, as it depends on how much alcohol you are consuming and how your body responds to alcohol

Tirzepatide associated with reduced albuminuria in participants with type 2 diabetes: Pooled post hoc analysis from the randomized active- and placebo-controlled SURPASS-15 clinical trials